Search
for
Sort by
Research 241–270 of 1000+
- Polycystic Ovary Syndrome in Adolescents
- Treatment of hyperandrogenism in women
- Dermatologic manifestations of endocrine disorders
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- Obesity and the skin
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Insulin Resistance and Skin Diseases
- 5α-Reduced glucocorticoids: a story of natural selection
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Physiologic changes and dermatoses of pregnancy
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Is polycystic ovary syndrome a sexual conflict? A review
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Endocrine disorders and hormonal therapy for adolescent acne
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- The Interrelation Between Hirsutism and Androgen Hormone Levels as Well as Serum TNFΑ Concentrations
- Subject Index
- Steroid Hormones of Reproduction and Sexual Development
- Drugs that affect autonomic functions or the extrapyramidal system
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome